Sponsorship Opportunities

Collaborating to Improve HPB Cancer Control in Africa: Prevention, Treatment, Research, and Survivorship

August 12-15th, 2026 Abuja, Nigeria

About AHPBCC

2026 Annual Conference

The mission of the AHPBCC is to expand knowledge of the epidemiology, etiology, pathobiology and prognosis of liver, biliary tract, and pancreatic cancers by:

  • Fostering collaborations between researchers and clinicians in different countries
  • Providing a framework for the efficient conduct and publication of original pooled analyses
  • Providing a forum and framework for discussion, development, and pursuit of new research directions
  • Supporting the development of early career researchers and clinicians 

The vision of the AHPBCC is to establish, develop, and support the efforts of a highly skilled network of liver, pancreatic, and biliary tract cancer researchers and clinicians on the African continent and worldwide.

About The Conference

The Africa HepatoPancreatoBiliary Cancer Consortium (AHPBCC) will hold its fifth annual scientific conference in Abuja, Nigeria, from August 12-15th, 2026. More than 300 attendees from across Africa and the world will gather the most up-to-date information during basic science, translational, and clinical research along with clinical care focused sessions to harness resources and expertise to address the increasing problem of higher incidence and mortality of hepatobiliary and pancreatic cancers in Africa.

We have solidified funds from several foundations and organizations, including an R13 grant award from the US National Cancer Institute. We are currently soliciting additional support. Specific sponsorship opportunities that may be aligned with your organization’s priorities include early-career investigator travel and funding seed grant collaborations between investigators in Africa and investigators from around the world for studies focused on hepatobiliary and pancreatic cancers.

The AHPBCC inaugural scientific conference “Transforming HepatoPancreatoBiliary Cancer Research and Care in the Omics Era,” was held in Cairo, Egypt in 2022. The second annual conference in 2023 was held in Accra, Ghana and included 250 attendees from 23 countries participating in nearly 40 hours of conference programming and workshops. The third conference in Mombasa, Kenya saw 264 in-person attendees from 29 countries. Our fifth conference in Johannesburg, South Africa saw 230 attendees from 29 countries.  We look forward to building on this success for the 2026 scientific conference in Abuja, Nigeria!

Why Sponsor

This meeting will give you the opportunity to collaborate with international key opinion leaders focused on advancing research, treatment, and care for liver, biliary tract, and pancreatic cancers. They will address the pressing need to:

  • Identify and empower emerging cancer researchers and clinicians with the most current knowledge and research skills in the field to contribute meaningfully to understanding the etiology and prognostic factors associated with these cancers
  • Help to develop sustainable, practical actions to reduce the incidence and mortality of these cancers in Africa

Harness our collective expertise and resources in the United States with African investigators to advance the science of hepatobiliary and pancreatic cancers in Africa

SEVERAL SPONSORSHIP OPPORTUNITIES TO MEET YOUR MARKETING NEEDS

For more information, or to discuss alternative sponsorship opportunities not listed,  please contact info@aildd.org

A Glimpse of the 2025 Conference

(Top) AHPBCC 2024 conference participants in Mombasa, Kenya. (Bottom left) Hands-on ultrasound workshop using live patient models at the AHPBCC 2022 meeting in Cairo, Egypt. (Bottom middle) Advanced endoscopy training workshop using both simulated models and live patient cases at the AHPBCC 2024 meeting at Coast Central Hospital in Mombasa, Kenya. (Bottom right) Poster session at the AHPBCC 2024 meeting in Mombasa, Kenya, featuring many young investigators and clinicians.